Brooks Nader Disclosed GLP-1 Weight Loss Use
The 29-year-old model recently shared her use of GLP-1 medication to lose 30 pounds for modeling work.
Updated on Oct. 4, 2026 in Weight Loss
Model Brooks Nader has publicly shared that she utilized GLP-1 drugs to lose 30 pounds. She attributed the decision to meeting specific requirements set by her modeling agency clients.
Why it matters
The disclosure highlights the increasing prevalence of GLP-1 medications within the fashion industry as professionals navigate strict physical standards. Her transparency offers insight into the behind-the-scenes demands placed on models to maintain specific body types for high-profile work.
Model Brooks Nader, 29, reported losing 30 pounds using GLP-1 drugs to satisfy client requirements. This weight management strategy follows her career as a model, which began in 2019.
The players
Brooks Nader
She is a 29-year-old model who recently completed filming for a reboot of the Baywatch television series.
The details
Nader, who recently attended the Mugler show during Paris Fashion Week and the Dolce & Gabbana show in Milan, coordinates her cosmetic procedures and appointments during gaps in her professional schedule. In addition to GLP-1 use, Nader has been open about undergoing rhinoplasty, liposuction, and Botox treatments, while utilizing veneers.
Timeline
Brooks Nader began her modeling career in 2019.
Nader admitted to undergoing rhinoplasty in a 2025 interview.
Filming for the Baywatch reboot concluded in Malibu in July 2026.
Nader attended Paris Fashion Week in October 2026.
Health Landscape
Nader's disclosure follows a broader trend of public figures and industry professionals utilizing GLP-1 medications for cosmetic weight management. This instance highlights how high-pressure aesthetic expectations continue to drive the adoption of medical weight-loss interventions.
Readers considering similar weight-loss pathways should recognize that such medications require medical oversight and carry potential side effects. Nader's experience underscores the importance of discussing specific weight-loss goals and hormonal health with a qualified provider.
The takeaway
Nader's decision to share her medical history illustrates the shift toward greater transparency regarding the cosmetic procedures used in the modeling industry. Individuals should prioritize consulting with medical professionals to understand the long-term implications of GLP-1 usage.
Further reading
Explore the broader medical and social impact of these treatments on our Weight Loss section.
